Pfm Health Sciences, LP Caribou Biosciences, Inc. Transaction History

Pfm Health Sciences, LP

$1.71 Billion
Q3 2024

A detailed history of Pfm Health Sciences, LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 4,306,671 shares of CRBU stock, worth $8.57 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

4,306,671

Previous 4,083,372 5.47%

Holding current value

$8.57 Million

Previous $6.7 Million 25.42%

% of portfolio

0.49%

Previous 0.34%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.56 - $2.73 $348,346 - $609,606	223,299 Added 5.47%	4,306,671 $8.4 Million
Q2 2024 Aug 14, 2024	SELL	$1.62 - $5.05 $3.89 Million - $12.1 Million	-2,399,898 Reduced 37.02%	4,083,372 $6.7 Million
Q1 2024 May 14, 2024	BUY	$4.82 - $8.26 $12,078 - $20,699	2,506 Added 0.04%	6,483,270 $33.3 Million
Q4 2023 Feb 14, 2024	SELL	$3.58 - $6.25 $873,344 - $1.52 Million	-243,951 Reduced 3.63%	6,480,764 $37.1 Million
Q3 2023 Nov 14, 2023	BUY	$4.08 - $8.14 $4.71 Million - $9.39 Million	1,153,846 Added 20.71%	6,724,715 $32.1 Million
Q2 2023 Aug 14, 2023	BUY	$4.04 - $5.47 $2.26 Million - $3.06 Million	558,751 Added 11.15%	5,570,869 $23.7 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $7.78 $2.38 Million - $4.3 Million	552,335 Added 12.38%	5,012,118 $26.6 Million
Q4 2022 Feb 14, 2023	SELL	$5.57 - $11.01 $8.58 Million - $17 Million	-1,540,217 Reduced 25.67%	4,459,783 $28 Million
Q2 2022 Aug 15, 2022	BUY	$5.1 - $9.74 $8.31 Million - $15.9 Million	1,629,455 Added 37.28%	6,000,000 $32.6 Million
Q1 2022 May 16, 2022	BUY	$8.42 - $15.32 $2.34 Million - $4.26 Million	278,236 Added 6.8%	4,370,545 $40.1 Million
Q3 2021 Nov 15, 2021	BUY	$15.75 - $30.29 $64.5 Million - $124 Million	4,092,309 New	4,092,309 $88.2 Million

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

52.6M

Call Options Held

148K

Put Options Held

70.7K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $121M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Account

Pfm Health Sciences, LP Caribou Biosciences, Inc. Transaction History